Get started
Author

Michael J. Knauer

Observed names: Knauer, Michael J., M. Knauer, Michael J Knauer, Michael Knauer
Observed institutions: Western University, Lawson Health Research Institute, University of Toronto, Vanderbilt University, Ottawa Hospital, London Health Sciences Centre, Clinical Pharmacology of Miami, St Joseph's Health Care
ORCID: 0000-0002-2240-4730
Observed ORCID: 0000-0002-2240-4730
OpenAlex ID: A5012520211
Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins
2009 · Michael J. Knauer, Bradley L. Urquhart, et al. · Circulation Research · 222
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism
2022 · Maitray A. Patel, Michael J. Knauer, et al. · Molecular Medicine · 122
PDF
Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response
2012 · Inna Y. Gong, Natalie Crown, et al. · European Heart Journal · 85
PDF
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function
2023 · Cristiana Iosef, Michael J. Knauer, et al. · Journal of Translational Medicine · 70
PDF
Effect of CKD and Dialysis Modality on Exposure to Drugs Cleared by Nonrenal Mechanisms
2014 · Benjamin K.A. Thomson, Thomas D. Nolin, et al. · American Journal of Kidney Diseases · 65
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning
2023 · Maitray A. Patel, Michael J. Knauer, et al. · Molecular Medicine · 58
PDF
The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs
2009 · Bradley L. Urquhart, Jamie C. Gregor, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 55
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern
2021 · Courtney Voss, Sally Esmail, et al. · JCI Insight · 52
PDF
Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1
2019 · Samantha Medwid, Mandy M.J. Li, et al. · Drug Metabolism and Disposition · 51
PDF
Transport Function and Transcriptional Regulation of a Liver-Enriched Human Organic Anion Transporting Polypeptide 2B1 Transcriptional Start Site Variant
2013 · Michael J. Knauer, Anthea J. Girdwood, et al. · Molecular Pharmacology · 37
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab
2021 · Amrit Kirpalani, Justin Garabon, et al. · British Journal of Haematology · 30
PDF
Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer
2017 · Angela W.S. Fung, Michael J. Knauer, et al. · F1000Research · 30
PDF
Quality assurance practices for point of care testing programs: Recommendations by the Canadian society of clinical chemists point of care testing interest group
2020 · Allison A. Venner, Lori A. Beach, et al. · Clinical Biochemistry · 29
Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies
2021 · Sally Esmail, Michael J. Knauer, et al. · Cell Reports Methods · 19
Renal Infarcts—A Perplexing Case in the Middle of the COVID-19 Pandemic
2021 · Brett Plouffe, Tamara Van Hooren, et al. · Frontiers in Pediatrics · 13
PDF
Randomized open‐label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas‐kidney patients
2017 · Mark Cattral, Sean Luke, et al. · Clinical Transplantation · 11
Clopidogrel and CYP2C19: Pharmacogenetic Testing Ready for Clinical Prime Time?
2015 · Michael J Knauer, Eleftherios P Diamandis, et al. · Clinical Chemistry · 10
Validation of Analytical Performance Limits for Accuracy with High-Sensitivity Cardiac Troponin Assays
2024 · Peter A Kavsak, Alexander Kumaritakis, et al. · Clinical Chemistry · 8
PDF
Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest Groups
2023 · Julie L.V. Shaw, Saranya Arnoldo, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 8
PDF
Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection and quality management of SARS-CoV-2 point-of-care tests
2021 · Jennifer Taher, Edward W. Randell, et al. · Clinical Biochemistry · 6
Interim analysis of the clinical performance of five SARS-Cov-2 serology assays
2020 · Michael J. Knauer, Benjamin D. Hedley, et al. · Clinical Biochemistry · 6
Investigation of N,N,N-Trimethyl-L-alanyl-L-proline Betaine (TMAP) as a Biomarker of Kidney Function
2023 · Nicole A. Sidor, Thomas J. Velenosi, et al. · ACS Omega · 4
PDF
Dried blood spots for therapeutic drug monitoring of tacrolimus and sirolimus in pediatric patients
2014 · Bradley L. Urquhart, Michael J. Knauer · Pediatric Transplantation · 4
Precision of point of care glucose metre measurements in the context of neonatal hypoglycemia
2024 · Julie L V Shaw, Saranya Arnoldo, et al. · Paediatrics & Child Health · 3
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study
2024 · Alexandra Hillyer, Anthony Quint, et al. · Clinical Lymphoma Myeloma & Leukemia · 3
PDF
Works count: 48
Citation count: 1,015
H-index: 14
I10-index: 17
Year
Topic
Type